Genomma Labs to Acquire Prestige Brands for $834 Million

Roche Holding AG’s pursuit of Illumina Inc. is putting companies from Life Technologies Corp. to Genomic Health Inc. in play as health-care providers turn to DNA to tailor treatments for cancer and inherited diseases.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.